Top Ten things you need to know… About VAD’s Kim Byrum Chappell Mechanical Assist Coordinator.

Slides:



Advertisements
Similar presentations
Figure 2 Projected Total Costs During Bridging Period LOWER COSTS ASSOCIATED WITH HOME DISCHARGE OF BRIDGE-TO-TRANSPLANT PATIENTS USING THE TLC-II PORTABLE.
Advertisements

Community Preparation for Caring for Mechanical Circulatory Device Patients University of Wisconsin Hospital And Clinics Ventricular Assist Device Program.
An Overview of Ventricular Assist Devices Pre Hospital Management
Left Ventricular Assist Devices “LVAD”
Pre-Hospital Care of the Mechanical Circulatory Support Device Patient
BACKGROUND Ventricular assist devices (VADs) are a proven therapy as bridge-to-cardiac transplantation in Class IIIB and Class IV heart failure patients.
April Staff Meeting 2pm. Kim Byrum Chappell Mechanical Assist Coordinator.
BACKGROUND Ventricular assist devices (VADs) are a proven therapy as bridge-to-cardiac transplantation in Class IIIB and Class IV heart failure patients.
Clinical Assessment of Pulsatile and Non-Pulsaltile VADs Diana Joseph RN, BSN, CCTC VAD/Heart Transplant Coordinator OSF St. Francis Medical Center Peoria,
Topics Zoll LifeVest  What it is  Who it treats  How does EMS handle these patients?
Vitals and History Taking Hillcrest Fire Training December, 2000.
Dennis Prentice – Project Manager (ME) Anthony Culotta – Mechanical Engineer Jason Nichols – Mechanical Engineer Belinda Segui – Electrical Engineer Sponsor/Advisor:
Equipoise Does Not Exist for REVIVE IT Andrew Boyle, MD Heart and Vascular Center Director, Florida Chairman of Cardiology Medical Director of Heart Failure,
VAD Resource Team University of Washington Medical Center
Left Ventricular Assist Devices: The What and the Who Lance E. Sullenberger MD FACC FACP Capital Cardiology Associates.
Community Preparation for Caring for Mechanical Circulatory Device Patients University of Wisconsin Hospital And Clinics Ventricular Assist Device Program.
Mechanical Circulatory Support for Advanced Heart Failure Speakers: Lynne A Benish, ACNP-BC Mechanical Assist Device Nurse Practitioner, Cardiac Surgery.
Rejection Normal response Inflammation 25% of pt. will have acute rejection during the first year post transplant Causes: Previous Rejection Noncompliance.
Advances In LVAD Patient Management
Introduction to Ventricular Assist Device (VAD)
Ventricular Assist Devices
9/5/20151 Ventricular Assist Device (VAD) Patients in the Community Liz Amerman, RN, BSN IU Health Methodist VAD Program Manager April 18, 2012.
Silver Cross EMSS March 2013 EMD CE LVAD.
Ventricular Assist Device: An Advanced Surgical Intervention for the Treatment of End Stage Heart Failure Laura Coyle, MSN, ACNP-BC VAD Coordinator Advocate.
Transition to Next Level of Care Management of Patient with Ventricular Assist Device Hospital Home Transition.
Contemporary Outcomes With the HeartMate II® LVAS
LVAD BASICS HEART MATE II
Created by Lt. S. Albright – Paramedic SCEMS Triage Tag Training Manual.
Hospital Care Structure and Self- Care Education Processes of Ventricular Assist Device Programs: A National Study S. Brian Widmar PhD, RN, ACNP-BC Ann.
Community Preparation for Caring for Mechanical Circulatory Device Patients University of Wisconsin Hospital And Clinics Ventricular Assist Device Program.
Global Cardiac Assist Devices Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast,
Introduction Device infection remains a significant cause of morbidity and mortality in patients supported by mechanical assist devices. The infection.
Nick Dominesey Matthew Myers Michael Edson Ellie Sanford Chris Smith Jason Inman.
Ventricular Assist Devices A Ventricular assist device, or VAD, is a mechanical circulatory device that is used to partially or completely replace the.
INTERMACS: June 2006 – December 2012: CMS Report Adults: n=7849 All primary implants as of 12/31/2012 n= 7928 Pediatric patients: n=79 (patients < 19 yrs.
Risk Factors for Adverse Outcome after HeartMate II Jennifer Cowger, MD, MS St. Vincent Heart Center of Indiana Advanced Heart Failure, Transplant, & Mechanical.
Ventricular Assist Device: Intervals for dressing changes By. Megan Giska.
Advanced Therapies Lee R. Goldberg, MD, MPH Medical Director, Heart Failure and Cardiac Transplant Program University of Pennsylvania.
Mechanical Circulatory Support in Special Populations Renzo Y. Loyaga-Rendon MD.,PhD.. Assistant Professor Advanced Heart Failure Section University of.
Differences in Pulsatile vs. Continuous-Flow Left Ventricular Assist Devices on Renal Function Antone Tatooles, MD; Laura A. Coyle, MSN, ACNP-BC; Colleen.
Extracorporeal Membrane Oxygenation for Bridge to Decision and to Recovery Shigeki Tabata, Hitoshi Hirose, Nicholas C. Cavarocchi, James T. Diehl, Hiroyuki.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Results of the Destination Therapy Post-Food and.
Centrifugal or Axial LVAD? : Denis Papin versus Archimedes
Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:
University of Chicago Medicine
“ ” It was the right time for an expert second opinion.
Ventricular Assist Device
Ventricular function recovery on LVAD For idiopathic or ischemic CM
Mechanical circulatory support
Ventricular assist device (VAD) patient in action
Αντιμετώπιση καρδιακής ανεπάρκειας προχωρημένου και τελικού σταδίου
Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score 
Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients  James K. Kirklin, MD, David C. Naftel,
University of Wisconsin Hospital And Clinics
Effectiveness of a Shared Decision Making Intervention for Patients Offered a Destination Therapy Left Ventricular Assist Device for End-Stage Heart.
Kbv Research | +1 (646) | Global Ventricular Assist Devices Market Knowledge Based Value (KBV) Research Full report :
Henry Ford Health System
Mechanical Circulatory Support Devices HOSEIN PASANDI.
Durable Mechanical Circulatory Support in Advanced Heart Failure
Impact of Marital Status on LVAD Mortality: A Single Center Experience Linda Njoroge MD, Mohamed Khayata MD, Kevin Charnas, Paul Bate, Madison Edge, James.
Mandeep R. Mehra, MD, Nir Uriel, MD, Joseph C. Cleveland, Jr
Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9- Year Experience  Jeffrey A. Morgan, MD, Pauline H. Go, MD, Linnea.
Jerry D. Estep et al. JCHF 2013;1:
Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011  William L.
Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure  Erin M. Schumer,
MOMENTUM 3 Trial design: Patients with advanced heart failure were randomized to a centrifugal-flow pump (n = 152) vs. an axial-flow pump (n = 142). Results.
Heartware HVAD Ventricular Assist System
Current Status of Left Ventricular Assist Device Therapy
Daisuke Yoshioka, MD, Hiroo Takayama, MD, Arthur R. Garan, MD, Veli K
Presentation transcript:

Top Ten things you need to know… About VAD’s Kim Byrum Chappell Mechanical Assist Coordinator

#1: VAD stands for: Ventricular Assist Device

#2: Why are they used? End stage Heart Failure BTT (Bridge to Transplant) – Vanderbilt – Under the watchful eye of the Transplant Coordinators DT (Destination Therapy) – St. Thomas. These patients will live with this device until death. They are not transplant candidates.

#3: Types of VAD’s Pulsatile Continuous Flow – Axial Flow – Centrifugal Flow

#4: VAD’s in the Nashville Community Currently 8 patients are followed by Vanderbilt St Thomas also implants VAD’s and those patients could show up at our doorstep The current VAD you would encounter in the ER is CONTINUOUS FLOW VAD called the Heart Mate II (HMII) made by Thoratec, Inc. (Axial Flow)

#5: Continuous Flow = No Pulsatility Will most likely not be able to palpate peripheral pulses Most likely unable to obtain SBP/DBP Most reliable/accurate measurement is by Doppler Document under Manual MAP

#6: Medications VAD patients will be on anticoagulants – Coumadin Aspirin Rare – Persantine, Plavix, More rare/rumor – Dabigatran: there has been discussion around this Afib approved drug but it has not been used here…..no antidote.

#7: Components Pump – inside the patient (sounds like humming) Driveline – white tube; exits somewhere in the abdominal area System Controller – the brains Battery or Power Base Unit – the power

#8: Patients know their “stuff” Will bring a back up system controller & batteries in case of a failure; typically in a black bag. Must remain with patient at all times, for all tests/procedures, transport, etc. Do not unplug cables to silence any alarm. Do not unplug both power cables at the same time.

#9. Resources VAD pager # Thoratec supplied items: – Clinical Operations and Patient Management book – HMII Information and Emergency Assistance Guide pamphlet – HMII LVAD Pocket Guide to alarms for Clinicians – Outpatient Emergency Response Program CD – Thoratec Thoratec.com

#10: Remember….. If they are speaking to you, if they are warm, pink & with brisk capillary refill they are perfusing. It’s a patient with a pump, not a pump with a patient – so treat the patient. Can auscultate the pump Floors trained in VAD patients: 5N & 7N You can’t always tell a VAD patient at first glance